PT Volume 35, Issue 6, pp. 44-488 June 2011
BUBENDORF, Switzerland (June 8, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, was featured:
1) in the June issue of Pharmaceutical Technology (Volume 35, Issue 6, pp. 44-48). Patricia Van Arnum, correspondent for Pharmaceutical Technology interviewed Charlie Johnson, Head of High Potency Business Unit, CARBOGEN AMCIS for PT’s report on APIs and excipients entitled, “High-Potency and High-Containment Manufacturing.”
Johnson discussed with Van Arnum about the different milling techniques for powder handling and PS control for high-potency APIs and about CARBOGEN AMCIS’ exposure risk matrix to manage the risk of handling dry, dusty solids.
Pharmaceutical Technology is a monthly magazine published by Advanstar Communications, Inc. with a total qualified circulation of 38,600, according to their website. Pharmaceutical Technology covers process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.
2) in ICMS (Ingredients and Contract Manufacturing Solutions), the pullout section of European Pharmaceutical Manufacturer (EPM). Elizabeth Valero, editor of EPM interviewed Charlie Johnson, Head of High Potency Business Unit, CARBOGEN AMCIS for an Executive Q&A appearing on the May issue of ICMS on High Potency.
Johnson talked about the recent successful containment performance validation of CARBOGEN AMCIS’ High Potency facility located on the site of its parent company, Dishman Pharmaceuticals and Chemicals Ltd., in Ahmedabad, India. Furthermore, he gave an insight into the most recent developments in the company’s High Potency business.
European Pharmaceutical Manufacturer (EPM) is a magazine focused on the manufacture of pharmaceuticals. ICMS (Ingredients and Contract Manufacturing Solutions) is a standalone, pullout section appearing in all issues of EPM and dedicated to promoting the pharmaceutical ingredients and contract manufacturing community. EPM is distributed to over 30 countries and has a global circulation of 23,000, according to their website.
The article can be viewed on line: http://www.epmmagazine.com/img/static/CARBOGENAMCISQandA2.pdf
CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.